Beam Therapeutics Inc. (BEAM) Ownership

$23.30

north_east
$0.43 (1.88%)
Day's range
$22.14
Day's range
$23.43

Beam Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FARALLON CAPITAL MANAGEMENT LLC 02/14/2025 8.24 M $204.33 M   0.38% 10.00%
BLACKROCK FUNDING, INC. /DE 02/07/2025 7.67 M $190.26 M   -0.99% 9.31%
VANGUARD GROUP INC 02/11/2025 7.62 M $189.03 M   -2.84% 9.25%
ARK INVESTMENT MANAGEMENT LLC 02/04/2025 7.07 M $175.29 M   8.22% 8.58%
ARCH VENTURE MANAGEMENT, LLC 02/14/2025 4.54 M $112.60 M   -6.09% 5.51%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 01/28/2025 3.96 M $98.15 M   11.39% 4.80%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 02/10/2025 3.96 M $98.11 M   11.39% 4.80%
FMR LLC 02/13/2025 3.32 M $82.27 M   -21.23% 4.03%
STATE STREET CORP 02/14/2025 3.08 M $76.32 M   -21.69% 3.73%
MWG MANAGEMENT LTD. 02/14/2025 2.27 M $56.22 M   0.00% 2.75%
CITADEL ADVISORS LLC 02/14/2025 2.06 M $51.14 M   37.83% 2.50%
UBS GROUP AG 02/14/2025 1.82 M $45.13 M   861.78% 2.21%
TEMASEK HOLDINGS (PRIVATE) LTD 02/14/2025 1.81 M $44.96 M   0.00% 2.20%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.80 M $44.76 M   -0.18% 2.19%
KYNAM CAPITAL MANAGEMENT, LP 02/14/2025 1.76 M $43.55 M   34.87% 2.13%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 1.75 M $43.48 M   17.95% 2.13%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 1.54 M $38.15 M   24.03% 1.87%
REDMILE GROUP, LLC 02/14/2025 1.53 M $37.91 M   -5.12% 1.85%
BELLEVUE GROUP AG 02/14/2025 1.52 M $37.65 M   0.00% 1.84%
CASDIN CAPITAL, LLC 02/14/2025 1.25 M $31.00 M   61.29% 1.52%
MORGAN STANLEY 02/14/2025 795,319 $19.72 M   -34.15% 0.97%
GOLDMAN SACHS GROUP INC 02/11/2025 719,864 $17.85 M   5.73% 0.87%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 648,945 $16.09 M   3.09% 0.79%
JPMORGAN CHASE & CO 02/12/2025 513,671 $12.74 M   -19.64% 0.62%
YIHENG CAPITAL MANAGEMENT, L.P. 02/11/2025 426,102 $10.57 M   -44.21% 0.52%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/14/2025 413,409 $10.25 M   -10.84% 0.50%
JANE STREET GROUP, LLC 02/14/2025 402,012 $9.97 M   113.73% 0.49%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 395,920 $9.82 M   -1.34% 0.48%
ALPHABET INC. 02/07/2025 321,604 $7.98 M   0.00% 0.39%
BAILLIE GIFFORD & CO 01/31/2025 308,236 $7.64 M   -13.83% 0.37%
WOODLINE PARTNERS LP 02/14/2025 282,120 $7.00 M   100.00% 0.34%
BARCLAYS PLC 02/13/2025 278,019 $6.90 M   51.75% 0.34%
BANK OF NEW YORK MELLON CORP 02/04/2025 276,917 $6.87 M   21.70% 0.34%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 252,223 $6.26 M   0.92% 0.31%
ALLIANCEBERNSTEIN L.P. 02/12/2025 212,804 $5.28 M   149.45% 0.26%
POLAR ASSET MANAGEMENT PARTNERS INC. 02/25/2025 208,255 $5.16 M   901.23% 0.25%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 193,356 $4.80 M   100.00% 0.23%
TD ASSET MANAGEMENT INC 02/11/2025 184,306 $4.57 M   0.00% 0.22%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 181,636 $4.50 M   -1.60% 0.22%
RUSSELL INVESTMENTS GROUP, LTD. 02/13/2025 176,181 $4.37 M   -6.21% 0.21%
VESTMARK ADVISORY SOLUTIONS, INC. 02/06/2025 173,152 $4.48 M   29.31% 0.21%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 162,407 $4.03 M   3.92% 0.20%
01/30/2025 158,550 $3.93 M   100.00% 0.19%
SQUAREPOINT OPS LLC 02/14/2025 155,278 $3.85 M   100.00% 0.19%
CITIGROUP INC 02/12/2025 154,726 $3.84 M   44.09% 0.19%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 143,502 $3.56 M   -1.61% 0.17%
SWISS NATIONAL BANK 02/10/2025 137,800 $3.42 M   0.80% 0.17%
AMERICAN CENTURY COMPANIES INC 02/11/2025 135,380 $3.36 M   13.19% 0.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 133,600 $3.31 M   -40.52% 0.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 130,436 $3.23 M   52.29% 0.16%

Beam Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 269 institutional investors and hedge funds held shares of Beam Therapeutics Inc.. The most heavily invested institutionals were:

FARALLON CAPITAL MANAGEMENT LLC: 8.24 M

BlackRock Funding, Inc. /DE: 7.67 M

VANGUARD GROUP INC: 7.62 M

ARK Investment Management LLC: 7.07 M

ARCH Venture Management, LLC: 4.54 M

Sumitomo Mitsui Trust Holdings, Inc.: 3.96 M

98.87% of Beam Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 90.32 M shares in the last 24 months. This purchase volume represents approximately $2.10 B in transactions.